Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06722755 · ClinicalTrials.gov registry record · NA
Stroke and CPAP Outcome Study 3 Randomized Controlled Trial
A NA study of CPAP and Stroke Patients, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT06722755: Recruiting NA study of CPAP and Stroke Patients, sponsored by University of Washington.
NCT06722755 is a NA study of CPAP and Stroke Patients that is actively recruiting participants, run by University of Washington. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06722755, a NA study of CPAP and Stroke Patients, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
The SCOUTS 3 study aims to test the effectiveness of an intensive CPAP (Continuous Positive Airway Pressure) therapy support program compared to usual care in stroke patients with obstructive sleep apnea (OSA) during inpatient rehabilitation (IPR). The study is a multicenter randomized controlled trial (RCT) involving recruitment of about 250 participants across two institutions and randomization of about 200 participants. It compares an intensive support (IS) program for CPAP use with standard support (SS) to evaluate the effectiveness of the IS intervention in increasing CPAP usage during and after stroke rehabilitation. The Intensive Support (IS) group will receive a multicomponent intensive behavioral adherence program, which includes a CPAP technical support intervention, Motivational Enhancement Therapy (MET), and a Mobile Health intervention. Outcomes measured include CPAP adherence as measured by average nightly use in minutes between randomization and 3 months and the modified Rankin Scale (mRS-9Q) to evaluate stroke recovery.
Primary Outcome
Average nightly minutes of CPAP use over the 90-day period is passively transmitted from a modem in each CPAP device via cellular service and securely accessed via the ResMed program, AirView. Alternatively, data cards can be obtained and downloaded.
Conditions Studied
Interventions
- DEVICE CPAP device
- BEHAVIORAL CPAP technical support
- BEHAVIORAL Phone follow-up for adherence feedback and self-management skills
- BEHAVIORAL myAir
- BEHAVIORAL Tailored messages
Study Locations (2)
California
- Rancho Research Institute - Downey
Washington
- University of Washington - Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2028-05 |
| Phase | NA |
What NCT06722755 shows while recruiting
NCT06722755 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 3 conditions, with CPAP appearing as the primary indexed condition, and to 5 interventions - of which CPAP device is the first listed.
NCT06722755 reports a single indexed study location in California, Washington.
Frequently Asked Questions
What is clinical trial NCT06722755 about?
NCT06722755 is a clinical study titled "Stroke and CPAP Outcome Study 3 Randomized Controlled Trial". The SCOUTS 3 study aims to test the effectiveness of an intensive CPAP (Continuous Positive Airway Pressure) therapy support program compared to usual care in stroke patients with obstructive sleep apnea (OSA) during inpatient rehabilitation (IPR). The study is a multicenter randomized controlled t...
What is the current status of trial NCT06722755?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-01-15. Estimated completion is 2028-05.
What conditions does trial NCT06722755 study?
This clinical trial studies the following conditions: CPAP, Stroke Patients, OSA - Obstructive Sleep Apnea.
What interventions are being tested in trial NCT06722755?
The interventions under investigation include: CPAP device (DEVICE), CPAP technical support (BEHAVIORAL), Phone follow-up for adherence feedback and self-management skills (BEHAVIORAL), myAir (BEHAVIORAL), Tailored messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT06722755?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06722755 being conducted?
This trial has 2 study locations across California, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for CPAP
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06722755's enrollment target sits among peer trials
250 410th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI